GLP-1 drugs work for weight loss, study finds
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated that almost 50 million adults in employer plans meet the clinical criteria for taking such drugs, which can cost thousands of dollars annually per person," according to a report from Kaiser Family Health (KFF) in October.
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
While GLP-1 medications like Ozempic and Wegovy have garnered significant attention, bariatric surgery continues to ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...
GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback